Niemann-Pick Disease Type C: Mutation Spectrum and Novel Sequence Variations in the Human NPC1 Gene

• Published in: Molecular neurobiology 2019-09, Vol.56 (9), p.6426-6435
• Main Authors: Polese-Bonatto, Márcia, Bock, Hugo, Farias, Ana Carolina S., Mergener, Rafaella, Matte, Maria Cristina, Gil, Mirela S., Nepomuceno, Felipe, Souza, Fernanda T. S., Gus, Rejane, Giugliani, Roberto, Saraiva-Pereira, Maria Luiza
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Alleles; Amino Acid Sequence; Base Sequence; Biomedical and Life Sciences; Biomedicine; Brain diseases; Cell Biology; Child, Preschool; Cholesterol; Female; Gene deletion; Genetic disorders; Glycolipids; Hereditary diseases; Humans; Infant; Intracellular Signaling Peptides and Proteins - chemistry; Intracellular Signaling Peptides and Proteins - genetics; Male; Metabolic disorders; Missense mutation; Mutation; Mutation - genetics; Neurobiology; Neurology; Neurosciences; Niemann-Pick disease; Niemann-Pick Disease, Type C - genetics; Npc1 protein; Nucleotide sequence; Protein Structure, Secondary
• ISSN: 0893-7648; 1559-1182
• DOI: 10.1007/s12035-019-1528-z

Niemann-Pick type C (NP-C) is a rare autosomal recessive disorder characterized by storage of unesterified glycolipids and cholesterol in lysosome and/or late endosome due to mutations in either NPC1 or NPC2 gene. This study aims to identify the spectrum of sequence alterations associated to NP-C in individuals with clinical suspicion of this disease. The entire coding region and flanking sequences of both genes associated to NP-C were evaluated in a total of 265 individuals that were referred to our laboratory. Clinical and/or biochemical suspicion of NP-C was confirmed by molecular analysis in 54 subjects. In this cohort, 33 different sequence alterations were identified in NPC1 and one in NPC2 . Among those, 5 novel alterations in NPC1 gene were identified as follows: one deletion (p.Lys38_Tyr40del), one frameshift (p.Asn195Lysfs*2), and three missense mutations (p.Cys238Arg, p.Ser365Pro and, p.Val694Met) that are likely to be pathogenic through different approaches, including in silico tools as well as multiple sequence alignment throughout different species. We have also reported main clinical symptoms of patients with novel alterations and distribution of frequent symptoms in the cohort. Findings reported here contribute to the knowledge of mutation spectrum of NP-C, defining frequent mutations as well as novel sequence alterations associated to the disease.